The new Connecticut law also limits “a health carrier’s use of step therapy,” which is a prescription drug protocol that ...

Patients with rheumatoid arthritis who undergo immune checkpoint inhibition for metastatic non-small cell lung cancer demonstrate similar overall survival as those without RA, according to data ...

Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating ...

The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

The American Massage Therapy Association (AMTA) is committed to advancing integrative health care by spotlighting the powerful role massage therapy can play in supporting individuals with autoimmune ...

Biocon Biologics launches Nepexto, a biosimilar for autoimmune diseases like rheumatoid arthritis, in Australia. The drug ...

Biocon Biologics, a subsidiary of Biocon, has introduced Nepexto, a biosimilar to Enbrel, in the Australian market for ...

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

Medicare drug plans may cover Rinvoq, but the specifics of coverage and out-of-pocket costs can differ depending on a person's specific plan.

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it ...

The research highlights the potential of these immune proteins to enhance the effectiveness of checkpoint inhibitors in certain individuals.